PMID: 18724516Aug 30, 2008Paper

Restoring treatment with continuous insulin infusion pump (BICI)

Revista de enfermería
Ana Ma Méndez López

Abstract

Significant advances in the treatment of diabetes have been made over the past few decades, although insulin treatment is the only option available until now for Type I diabetes patients. Type I diabetes is generally diagnosed in youths; therefore, micro insulin injectors enable doctors to offer them a better life style, preventing future complications. Medical professionals contemplate the possibility to use this treatment on patients over age 60 with satisfactory results. Continuous insulin infusion pumps (BICI) provide physiologically programmable subcutaneous administration of rapid acting insulin. Due to technological advances, these pumps have become safer more efficient and easier to use which improves the glucose level in blood and enables diabetes patients to carry out many activities without losing metabolic control, reduces the incidences of hypoglycemia and improves diabetes patients' life styles.

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Related Papers

The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
Jennifer Justice GorrellPaula Powell
Diabetes Care
J L Selam, M A Charles
Therapeutische Umschau. Revue thérapeutique
G A Spinas, W Berger
© 2022 Meta ULC. All rights reserved